Politiparty
Politiparty

118th Congress Health

S. 3311: American Made Pharmaceuticals Act of 2023

Introduced

  1. Introduced (completed)Nov 15, 2023
  2. Passed Senate (not reached)
  3. Passed House (not reached)
  4. To the President (not reached)
  5. Became law (not reached)

Summary

Introduced in Senate, Nov 15, 2023

This bill requires the Centers for Medicare & Medicaid Services to conduct a demonstration program that gives preference to domestically manufactured drugs under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP).

The program must be conducted in at least eight states and for at least seven years. Applicable drugs include critical drugs that are needed to respond to a public health emergency and that have a vulnerable global supply chain. Preference may take the form of reduced cost-sharing, preferential treatment on formularies, bonus payments, and other specified methods.

Written by the Congressional Research Service, Library of Congress.

Roll calls

0 votes on this bill

No roll call votes have been held on this bill.

Amendments

0 offered

No amendments were offered to this bill.

Cosponsors

2

Bipartisan support.

Who scored on this bill

6 points earned
  1. 1Tina Smith D-MN SponsorDrew cross-party cosponsors, introduced2 events+6
See all scorers and every scoring event

Introductions and cosponsorships count toward weekly caps and show no points.

Other bills by Tina Smith

History

  1. Nov 15, 2023Introduced in the Senate by Tina Smith.
Show the full action history (3 actions)
  1. Jul 25, 2024Committee on Banking, Housing, and Urban Affairs. Hearings held. Hearings printed: S.Hrg. 118-655.
  2. Nov 15, 2023Introduced in Senate
  3. Nov 15, 2023Read twice and referred to the Committee on Finance.